Is there any benefit to extending the dosing interval of ixekizumab in patients with stable psoriasis?
Featuring Tina Bhutani, MD, MAS |
CEO, Synergy Dermatology
Associate Clinical Professor of Dermatology
University of California, SF
San Francisco, CA
Related Media
Powered by Polaris TM